Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine
Barney S. Graham(National Institutes of Health), Gary J. Nabel(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Mary E. Enama(National Institutes of Health), Laurie Lamoreaux(University of Washington), Robert T. Bailer(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Bimal K. Chakrabarti(University of Vienna), Margaret McCluskey(National Institutes of Health), Phillip L. Gomez(National Institutes of Health), Mario Roederer(National Institutes of Health), Zoe Moodie(Fred Hutch Cancer Center), Julie E. Martin(National Institutes of Health), Charla Andrews(National Institutes of Health)
Cited by 220
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k